neither is presented as superior, and a clinician determines which, if either, fits
at 1-800-845-8210 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch Drug Interactions Hepatic enzyme-inducing drugs (e.g., phenytoin, carbamazepine, phenobarbital, primidone, rifampin) can increase valproate clearance, while enzyme inhibitors (e.g., felbamate) can decrease valproate clearance
Their model centers on matching patients with licensed providers for initial consultation, ongoing monitoring, and prescription management
While overall telehealth utilization peaked during the COVID-19 pandemic, recent data indicate a modest decline in total visits, suggesting that adoption remains concentrated in discrete applications rather than broad, systemwide use